成人慢性疼痛介入治疗中皮质类固醇的使用:交感神经与周围神经阻滞及触发点注射指南
该指南由美国区域麻醉与疼痛医学学会等四家学会共同制定,采用改良Delphi流程和USPSTF证据分级,针对成人慢性疼痛的交感神经阻滞、周围神经阻滞和触发点注射中皮质类固醇的使用与安全性给出推荐。指南指出影像引导可提高部分操作安全性,非颗粒型皮质类固醇加入局麻药对丛集性头痛有益,对其他类型头痛无益,对腹横肌平面阻滞和髂腹股沟/髂腹下神经阻滞可能额外获益,对阴部神经阻滞无证据,对触发点注射获益甚微。
要点
- 影像引导可提高星状神经节阻滞、下肢周围神经阻滞及部分触发点注射的安全性。
- 非颗粒型皮质类固醇加入局麻药对丛集性头痛有益,对其他类型头痛无益。
- 皮质类固醇对腹横肌平面阻滞和髂腹股沟/髂腹下神经阻滞可能额外获益,对阴部神经阻滞无证据,对触发点注射获益甚微。
核心结论
- 指南为交感神经阻滞、周围神经阻滞和触发点注射中皮质类固醇的使用提供推荐,以辅助临床决策。
研究设计与样本
- 指南制定经美国区域麻醉与疼痛医学学会董事会批准,多家学会参与,采用改良Delphi流程(共识≥75%)和USPSTF证据分级。
主要发现
- 影像引导可提高星状神经节阻滞、下肢周围神经阻滞及部分触发点注射部位的安全性。
- 非颗粒型皮质类固醇加入局麻药对丛集性头痛有益,但对其他类型头痛无益。
- 皮质类固醇对腹横肌平面阻滞和髂腹股沟/髂腹下神经阻滞在疝修补术后疼痛中可能额外获益,但对阴部神经阻滞无证据。
- 皮质类固醇在触发点注射中获益甚微。
临床怎么用
- 临床决策时应结合具体阻滞类型和疼痛状况,参考指南推荐使用皮质类固醇。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is potential for adverse events from corticosteroid injections, including increase in blood glucose, decrease in bone mineral density and suppression of the hypothalamic-pituitary axis. Published studies note that doses lower than those commonly injected provide similar benefit. METHODS: Development of the practice guideline was approved by the Board of Directors of American Society of Regional Anesthesia and Pain Medicine with several other societies agreeing to participate. The scope of guidelines was agreed on to include safety of the injection technique (landmark-guided, ultrasound or radiology-aided injections); effect of the addition of the corticosteroid on the efficacy of the injectate (local anesthetic or saline); and adverse events related to the injection. Based on preliminary discussions, it was decided to structure the topics into three separate guidelines as follows: (1) sympathetic, peripheral nerve blocks and trigger point injections; (2) joints; and (3) neuraxial, facet, sacroiliac joints and related topics (vaccine and anticoagulants). Experts were assigned topics to perform a comprehensive review of the literature and to draft statements and recommendations, which were refined and voted for consensus (≥75% agreement) using a modified Delphi process. The United States Preventive Services Task Force grading of evidence and strength of recommendation was followed. RESULTS: This guideline deals with the use and safety of corticosteroid injections for sympathetic, peripheral nerve blocks and trigger point injections for adult chronic pain conditions. All the statements and recommendations were approved by all participants after four rounds of discussion. The Practice Guidelines Committees and Board of Directors of the participating societies also approved all the statements and recommendations. The safety of some procedures, including stellate blocks, lower extremity peripheral nerve blocks and some sites of trigger point injections, is improved by imaging guidance. The addition of non-particulate corticosteroid to the local anesthetic is beneficial in cluster headaches but not in other types of headaches. Corticosteroid may provide additional benefit in transverse abdominal plane blocks and ilioinguinal/iliohypogastric nerve blocks in postherniorrhaphy pain but there is no evidence for pudendal nerve blocks. There is minimal benefit for the use of corticosteroids in trigger point injections. CONCLUSIONS: In this practice guideline, we provided recommendations on the use of corticosteroids in sympathetic blocks, peripheral nerve blocks, and trigger point injections to assist clinicians in making informed decisions.
引用
- Benzon HT, Elmofty D, Shankar H, et al. Use of corticosteroids for adult chronic pain interventions: sympathetic and peripheral nerve blocks, trigger point injections - guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physicians, and the International Pain and Spine Intervention Society. Reg Anesth Pain Med. 2026. PMID: 39019502. doi:10.1136/rapm-2024-105593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。